Similar articles

• Late incidence and determinants of reoperation in patients with prosthetic heart valves.

  Ruel M, Kulik A, Rubens FD, Bédard P, Masters RG, Pipe AL, Mesana TG. Ruel M, et al. Eur J Cardiothorac Surg. 2004 Mar;25(3):364-70. doi: 10.1016/j.ejcts.2003.12.013. Eur J Cardiothorac Surg. 2004. PMID: 15019662
• Aortic valve replacement with the Hancock standard, Björk-Shiley, and Lillehei-Kaster prostheses. A comparison based on follow-up from 1 to 15 years.

  Milano AD, Bortolotti U, Mazzucco A, Guerra F, Magni A, Gallucci V. Milano AD, et al. J Thorac Cardiovasc Surg. 1989 Jul;98(1):37-47. J Thorac Cardiovasc Surg. 1989. PMID: 2739424
• Aortic and mitral valve replacement in children: is there any role for biologic and bioprosthetic substitutes?

  Alsoufi B, Manlhiot C, McCrindle BW, Canver CC, Sallehuddin A, Al-Oufi S, Joufan M, Al-Halees Z. Alsoufi B, et al. Eur J Cardiothorac Surg. 2009 Jul;36(1):84-90; discussion 90. doi: 10.1016/j.ejcts.2009.02.048. Epub 2009 Apr 14. Eur J Cardiothorac Surg. 2009. PMID: 19369085
• Mitral valve replacement: mechanical versus bioprosthetic valves--a clinical review.

  Rao V, Tong C, Ivanov J, Sever J, Goldman BS. Rao V, et al. Can J Cardiol. 1991 Jul-Aug;7(6):259-64. Can J Cardiol. 1991. PMID: 1893303 Review.
• Bioprosthetic valve failure.

  Schoen FJ, Kujovich JL, Levy RJ, Sutton MS. Schoen FJ, et al. Cardiovasc Clin. 1988;18(2):289-317. Cardiovasc Clin. 1988. PMID: 3275416 Review. No abstract available.